Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

1.63
Delayed Data
As of May 25
 -0.05 / -2.98%
Today’s Change
1.43
Today|||52-Week Range
4.84
-26.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues2.3M5.0M9.4M8.6M
 
 
 
 
 
Cost of Goods Sold2.9M2.1M3.8M3.7M
 
 
 
 
 
Depreciation And Amortization39.0K41.0K44.0K48.0K
 
 
 
 
 
 
Operating ExpensesGross Income-576.0K2.8M5.6M4.9M
 
 
 
 
 
General Expenses73.0M50.5M43.8M43.5M
 
 
 
 
 
Research And Development22.3M6.6M2.0M3.4M
 
 
 
 
 
Total Operating Expenses75.9M52.7M47.6M47.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-73.6M-47.7M-38.2M-38.7M
 
 
 
 
 
Extraordinary Credit39.0K55.0K4.1M5.6M
 
 
 
 
 
Interest Expense On Debt345.0K1.2M2.9M3.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-73.9M-48.9M-37.0M-36.1M
 
 
 
 
 
Income Taxes0.000.000.00-30.0K
 
 
Net Income-73.9M-48.9M-37.0M-36.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS224.9M225.0M235.9M246.7M
 
 
 
 
 
Shares To Calculate EPS Diluted224.9M225.0M235.9M246.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.22-$0.16-$0.15
 
 
 
 
 
EPS Diluted-$0.33-$0.22-$0.16-$0.15